Literature DB >> 26580789

[The State of Measles and Rubella in the WHO European region].

Mark Muscat, Myriam Ben Mamou, Abigail Shefer, Dragan Jankovic, Sergei Deshevoy, Robb Butler.   

Abstract

The long-standing and widespread use of vaccines against measles has resulted in a dramatic decline in cases and measles mortality worldwide compared with the pre-vaccination era.All regions of the World Health Organization (WHO) have measles elimination goals and the WHO regions of the Americas, Europe and Western Pacific also have rubella elimination goals. This article aims to report on progress toward elimination of measles and rubella in the WHO European Region based on the latest available data. We also discuss current challenges and actions needed to reach this goal in the Region. Despite substantial progress made towards controlling measles and rubella, the countries of the WHO European Region continue to face challenges in interrupting endemic transmission of these diseases. Widespread outbreaks and endemic transmission of measles and rubella persisted in some countries of the Region in 2014 and have continued in 2015. Interrupting endemic transmission in each and every country is necessary to declare elimination for the entire Region. High population immunity and high-quality surveillance are the cornerstones to eliminate measles and rubella. In the absence of sustained political commitment and implementation of the required strategies by all countries, the goal of eliminating these diseases in the WHO European Region is at stake.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26580789     DOI: 10.4321/S1135-57272015000400002

Source DB:  PubMed          Journal:  Rev Esp Salud Publica        ISSN: 1135-5727


  4 in total

1.  Long time immunogenicity of measles vaccine in the vaccination era: An open question.

Authors:  Maria Serena Gallone; Cinzia Germinario; Angela Larocca; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2016-09-26       Impact factor: 3.452

2.  Community-wide measles outbreak in the Region of Madrid, Spain, 10 years after the implementation of the Elimination Plan, 2011-2012.

Authors:  L García Comas; M Ordobás Gavín; J C Sanz Moreno; B Ramos Blázquez; E Rodríguez Baena; E Córdoba Deorador; M García Barquero; E Gil Montalbán; A Arce Arnáez; I Rodero Garduño; D Barranco Ordóñez; J Astray Mochales
Journal:  Hum Vaccin Immunother       Date:  2017-01-06       Impact factor: 3.452

3.  Combating Vaccine Hesitancy: Teaching the Next Generation to Navigate Through the Post Truth Era.

Authors:  Margarida Arede; Maria Bravo-Araya; Émilie Bouchard; Gurlal Singh Gill; Valerie Plajer; Adiba Shehraj; Yassir Adam Shuaib
Journal:  Front Public Health       Date:  2019-01-14

4.  A Rare Coincidence of Measles with Typhoid Fever.

Authors:  Omair Ul Haq Lodhi; Syed F Imam; Mahad Umer; Rizwan Zafar
Journal:  Cureus       Date:  2017-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.